Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Harm Reduction Journal|June 23, 2025
Highlighting variability in fentanyl test strip instructions using thematic content analysisCianna J Piercey, Claire L Pince, Hollis C KarolyJournal of Addiction Medicine|December 23, 2025
Naloxone Use, Carrying Practices, Prior Training, and Confidence in Overdose Response Among Attendees of a 4-Day Music Festival in ColoradoCianna J Piercey, Claire L Pince, Hollis C KarolyHarm Reduction Journal|March 6, 2026
Behavioral phenotypes associated with cannabis and alcohol substitutionClaire L Pince, Cianna J Piercey, Vanessa T Stallsmith, et al.Drug and Alcohol Dependence|September 7, 2025
Cannabis administration is associated with reduced alcohol consumption: Evidence from a novel laboratory co-administration paradigmClaire L Pince, Vanessa T Stallsmith, Cianna J Piercey, et al.Neuroscience and Biobehavioral Reviews|October 20, 2023
Role of aldosterone and mineralocorticoid receptor (MR) in addiction: A scoping reviewClaire L Pince, Kimberly E Whiting, Tammy Wang, et al.JCI Insight|May 16, 2023
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmissionVicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.Drug and Alcohol Dependence|January 7, 2025
Bariatric surgery and alcohol and substance use: A case-control survey studyShannon N Speed, Garrick T Sherman, Tammy Wang, et al.The Journal of Clinical Investigation|March 6, 2025
Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intakeMehdi Farokhnia, John Tazare, Claire L Pince, et al.The Journal of Pharmacology and Experimental Therapeutics|January 11, 2023
Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin ReceptorSara L Deschaine, Morten A Hedegaard, Claire L Pince, et al.Pageof 1